This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Millennium Pharmaceuticals Limited, Other. Active years: 1999-2002.
Company Filing History:
3 out of 854 
1 out of 834,350 Years Active: 1999-2002
Title: Dennis Huszar: Innovator in Cardiovascular and Weight Disorders Research
Introduction
Dennis Huszar is a notable inventor based in Acton, MA (US), recognized for his contributions to the fields of cardiovascular disease and body weight disorders. He holds a total of 4 patents, showcasing his innovative approach to medical research and treatment methodologies.
Latest Patents
Huszar's latest patents include significant advancements in the treatment and diagnosis of cardiovascular disease. One of his inventions focuses on the generation and phenotypic characterization of transgenic knockout homozygous rchd534 mutant mice. These mice exhibit characteristic symptoms of cardiovascular disease, making them valuable models for analyzing the role of the rchd534 protein in cardiovascular system development and homeostasis. Additionally, he has developed screening methods for compounds that may be useful in treating or preventing cardiovascular disease.
Another notable patent involves drug screening assays and therapeutic methods for addressing body weight disorders, such as obesity, anorexia, and cachexia. This invention utilizes the melanocortin 4-receptor (MC4-R) as a target for intervention, aiming to modulate its activity or expression to treat these disorders effectively.
Career Highlights
Throughout his career, Dennis Huszar has worked with prominent companies, including Millennium Pharmaceuticals Limited. His work has significantly impacted the understanding and treatment of cardiovascular and weight-related health issues.
Collaborations
Huszar has collaborated with esteemed colleagues, including Wei Gu and Frank Lee, contributing to the advancement of research in his field.
Conclusion
Dennis Huszar's innovative work in cardiovascular disease and body weight disorders highlights his commitment to improving health outcomes through research and invention. His contributions continue to pave the way for future advancements in medical science.